December 2021 Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was Coincidentally, on the same day, Prof Pfleger was announced as a Fellow of the British Pharmacological Prof Pfleger has served on the ASCEPT Board since 2016 and was Chair of the Scientific Advisory Committee

Kevin Pfleger and Dr. "Congratulations to Perkins Professor Kevin Pfleger and Dr Elizabeth Johnstone who were awarded one of

Kevin Wright on his new position as Director of Targeted and Immuno-oncology at GPCR Therapeutics, our Kevin Wright Joins GPCR Therapeutics as Director of Targeted and Immuno-oncology Sosei Heptares Adds

molecules Ross AD Bathgate September 15, 2021 at 9:00:00 PM Learn More >> Profiling of GPCR complexes Kevin Pfleger September 16, 2021 at 12:00:00 PM Learn More >> Phosphorylation of the M1 muscarinic acetylcholine

RAGE BioTech, a company founded on research co-developed by Professor Kevin Pfleger from Harry Perkins

Kevin Pfleger and Dr.